![](https://tapmi.finance/wp-content/uploads/2024/01/Screenshot-2024-01-11-at-9.46.59-PM-e1704989899760-1024x543.png)
Company Analysis Tega
Sun Pharmaceutical Industries Ltd, the fourth largest specialty generic pharmaceutical company globally with revenues exceeding US$ 5.1 billion, operates a network of over 40 manufacturing facilities. This infrastructure enables them to provide high-quality, cost-effective medicines, positioning them as a trusted choice for healthcare professionals and patients in more than 100 countries. Founded in 1983 by Mr. Dilip Shanghvi with an initial investment of INR 10,000 (US$150), Sun Pharma initially served as a pharmaceutical wholesaler.
Leave a comment